Novel 4-(2-arylidenehydrazineyl)thienopyrimidine derivatives as anticancer EGFR inhibitors: Design, synthesis, biological evaluation, kinome selectivity and in silico insights von Elsebaie, Heba A., El-Bastawissy, Eman A., Elberembally, Kamel M., Khaleel, Eman F., Badi, Rehab Mustafa, Shaldam, Moataz A., Eldehna, Wagdy M., Tawfik, Haytham O., El-Moselhy, Tarek F.

Volltext

Development of new thieno[2,3-d]pyrimidines as dual EGFR and STAT3 inhibitors endowed with anticancer and pro-apoptotic activities von Elsebaie, Heba A., El-Moselhy, Tarek F., El-Bastawissy, Eman A., Elberembally, Kamel M., Badi, Rehab Mustafa, Elkaeed, Eslam B., Shaldam, Moataz A., Eldehna, Wagdy M., Tawfik, Haytham O.

Volltext

Synthesis, docking, and biological evaluation of thiazolidinone derivatives against hepatitis C virus genotype 4a von Al-Behery, Ahmed S., Elberembally, Kamel M., Eldawy, Mohammed A.

Volltext